CDC-Informationen zu anaphylaktischen Schocks als Folge von Covid-19-Impfungen

CDC-Informationen zu anaphylaktischen Schocks als Folge von Covid-19-Impfungen

Die US-Gesundheitsbehörde Centers for Disease Control and Prevention hat nachfolgende Stellungnahme (Stand *December 18, 2020 at 2300 hrs EST und **December 19, 2020 at 0945 hrs EST) veröffentlicht:

Anaphylaxis in US Following COVID-19 Vaccination

December 18*, 2020 – CDC has identified 6 case reports of anaphylaxis following Pfizer-BioNTech vaccine meeting Brighton Collaboration criteria for anaphylaxis
–Cases were Brighton Collaboration levels 1 or 2
–Additional case reports have been reviewed and determined not anaphylaxis

Cases occurred within recommended observation window and were promptly treated

One case had a history of anaphylaxis following rabies vaccination

All suspect cases were notified through VAERS or CDC notification processes

These case reports are undergoing/will undergo clinical case review by CISA

December 19** –272,001 doses of vaccine have been administered

CDC Actions Following Reports

Close coordination with FDA

Discussions with CISA investigators, NIH, Medicine and Healthcare products Regulatory Agency (UK), Allergy/Immunology experts, and other partners
Published Interim Considerations:

Preparing for the Potential Management of Anaphylaxis at COVID-19 Vaccination Sites (https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/anaphylaxis-management.html)

V-safe Active Surveillance for COVID-19 Vaccines

Auszug:

Health impact Events by Dec, 18th:

3,150 people are unable to perform normal daily activities, unable to work, required care from doctor or health care professional

Das Originaldokument kann unter nachfolgendem Link eingesehen und/oder downgeloaded werden

CDC-Report

---